A First in Human Study of the New Oral Selective Estrogen Receptor Degrader AZD9496 for HR+/HER2− Advanced Breast Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-3102
Full Text
Open PDFAbstract
Available in full text
Date
February 13, 2018
Authors
Publisher
American Association for Cancer Research (AACR)